# Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment:  Guidance for Industry; Availability - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/acute-myeloid-leukemia-developing-drugs-and-biological-products-for-treatment-guidance-for-industry-availability/7511194b-76aa-4116-a433-198583956923

> FDA guidance document: Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment:  Guidance for Industry; Availability. Issue date: October 17, 2022. Get complete insights and analysis.

---

## Details

- Title: Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment:  Guidance for Industry; Availability
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2022-10-17
- Last Changed: 2024-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-1298">FDA-2020-D-1298</a>

## Related Documents

- [Premenopausal Women with Breast Cancer: Developing Drugs for Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/premenopausal-women-with-breast-cancer-developing-drugs-for-treatment-guidance-for-industry/03f0e242-74ab-4a8e-b4b3-5d5c1d720852)
- [Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bladder-cancer-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/b3fd959c-72c5-4e86-a4a9-5fa31d0ce7b7)
- [Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/renal-cell-carcinoma-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/db30c852-ed7b-4054-8906-3aadd3851179)